Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany · Delayed Price · Currency is EUR 0.8950
+0.0100 (1.13%)
Oct 6, 2026, 5:35 PM CET
ETR:MAK Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | -0.09 | -0 | - | - | - | - |
| 119.26 | 118.03 | 114 | 102.31 | 106.7 | 111.44 | |
Revenue Growth | -0.45% | 3.53% | 11.43% | -4.12% | -4.25% | -2.50% |
Cost of Revenue | 98.86 | 95.86 | 91.67 | 94.39 | 90.27 | 82.66 |
Gross Profit | 20.4 | 22.17 | 22.33 | 7.91 | 16.43 | 28.78 |
Selling, General & Admin | - | - | - | - | 0.25 | 0.29 |
Other Operating Expenses | 16.94 | 17.51 | 13.77 | 7.43 | 15.32 | 16.27 |
Operating Expenses | 25.75 | 26.33 | 26.32 | 17.17 | 26.58 | 27.67 |
Operating Income | -5.35 | -4.16 | -3.99 | -9.26 | -10.14 | 1.11 |
Interest Expense | -7.23 | -8.02 | -8.43 | -7.55 | -5.78 | -6.01 |
Interest & Investment Income | 0.12 | 0.08 | 0.38 | 0.16 | 0.05 | 0.08 |
Other Non Operating Income (Expenses) | 1.18 | 1.18 | 1.71 | 3.97 | 0.79 | 2.65 |
EBT Excluding Unusual Items | -11.29 | -10.91 | -10.33 | -12.69 | -15.08 | -2.17 |
Merger & Restructuring Charges | -1.95 | -1.95 | - | - | - | - |
Pretax Income | -13.24 | -12.87 | -10.33 | -12.69 | -15.08 | -2.17 |
Income Tax Expense | 0.47 | 1.1 | 2.88 | 1.67 | 1.25 | 0.52 |
Earnings From Continuing Operations | -13.71 | -13.96 | -13.21 | -14.36 | -16.33 | -2.69 |
Minority Interest in Earnings | 0.06 | 0.11 | 0.06 | 0.11 | 2.25 | 0.13 |
Net Income | -13.66 | -13.85 | -13.16 | -14.26 | -14.08 | -2.56 |
Net Income to Common | -13.66 | -13.85 | -13.16 | -14.26 | -14.08 | -2.56 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Outstanding (Diluted) | 21 | 21 | 21 | 21 | 21 | 21 |
Shares Change | -0.87% | - | - | - | - | - |
EPS (Basic) | -0.65 | -0.66 | -0.63 | -0.68 | -0.67 | -0.12 |
EPS (Diluted) | -0.65 | -0.66 | -0.63 | -0.68 | -0.67 | -0.12 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 10.97 | 11.16 | 13.86 | -1.44 | 2.33 | 15.33 |
Free Cash Flow Per Share | 0.52 | 0.53 | 0.66 | -0.07 | 0.11 | 0.73 |
Gross Margin | 17.10% | 18.78% | 19.59% | 7.74% | 15.40% | 25.83% |
Operating Margin | -4.49% | -3.53% | -3.50% | -9.05% | -9.51% | 1.00% |
Profit Margin | -11.45% | -11.74% | -11.54% | -13.94% | -13.19% | -2.30% |
Free Cash Flow Margin | 9.20% | 9.46% | 12.16% | -1.41% | 2.19% | 13.76% |
EBITDA | -2.24 | -1.04 | -0.78 | -6.06 | -6.95 | 4.25 |
EBITDA Margin | -1.87% | -0.88% | -0.68% | -5.92% | -6.52% | 3.81% |
D&A For EBITDA | 3.12 | 3.13 | 3.22 | 3.2 | 3.19 | 3.14 |
EBIT | -5.35 | -4.16 | -3.99 | -9.26 | -10.14 | 1.11 |
EBIT Margin | -4.49% | -3.53% | -3.50% | -9.05% | -9.51% | 1.00% |
Revenue as Reported | 126.81 | 125.58 | 123.46 | 114.94 | 114.29 | 119.65 |